Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
T Battelino, CM Alexander, SA Amiel… - The lancet Diabetes & …, 2023 - thelancet.com
Randomised controlled trials and other prospective clinical studies for novel medical
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …
[HTML][HTML] Continuous glucose monitor, insulin pump, and automated insulin delivery therapies for type 1 diabetes: an update on potential for cardiovascular benefits
ME Pauley, KL Tommerdahl, JK Snell-Bergeon… - Current cardiology …, 2022 - Springer
Abstract Purpose of Review The incidence of type 1 diabetes (T1D) is rising in all age
groups. T1D is associated with chronic microvascular and macrovascular complications but …
groups. T1D is associated with chronic microvascular and macrovascular complications but …
MiniMed 780G™ in 2-to 6-year-old children: safety and clinical outcomes after the first 12 weeks
MA Pulkkinen, TJ Varimo, ET Hakonen… - Diabetes technology …, 2023 - liebertpub.com
Objective: The safety and impact of the advanced hybrid closed-loop (AHCL) system on
glycemic outcome in 2-to 6-year-old children with type 1 diabetes and the diabetes distress …
glycemic outcome in 2-to 6-year-old children with type 1 diabetes and the diabetes distress …
MiniMed 780G six-month use in children and adolescents with type 1 diabetes: clinical targets and predictors of optimal glucose control
F Lombardo, S Passanisi, A Alibrandi… - Diabetes Technology …, 2023 - liebertpub.com
Background: The aim of this multicenter observational real-world study was to investigate
glycemic outcomes in children and adolescents with type 1 diabetes over the first 6-month …
glycemic outcomes in children and adolescents with type 1 diabetes over the first 6-month …
Comparison of glycemia risk index with time in range for assessing glycemic quality
JY Kim, JH Yoo, JH Kim - Diabetes Technology & Therapeutics, 2023 - liebertpub.com
Background: The glycemia risk index (GRI) is a novel composite continuous glucose
monitoring (CGM) metric that gives greater weight to hypoglycemia than to hyperglycemia …
monitoring (CGM) metric that gives greater weight to hypoglycemia than to hyperglycemia …
Continuous glucose monitoring metrics (mean glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic …
D Rodbard - Diabetes, Obesity and Metabolism, 2023 - Wiley Online Library
Aim To evaluate continuous glucose monitoring (CGM) metrics for use as alternatives to
glycated haemoglobin (HbA1c) to evaluate therapeutic efficacy. Methods We re‐analysed …
glycated haemoglobin (HbA1c) to evaluate therapeutic efficacy. Methods We re‐analysed …
Glucose monitoring metrics in individuals with type 1 diabetes using different treatment modalities: A real-world observational study
K Nørgaard, AG Ranjan, C Laugesen… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE This study aimed to investigate the association between continuous glucose
monitoring (CGM)-derived glycemic metrics and different insulin treatment modalities using …
monitoring (CGM)-derived glycemic metrics and different insulin treatment modalities using …
Essential continuous glucose monitoring metrics: the principal dimensions of glycemic control in diabetes
E Montaser, C Fabris, B Kovatchev - Diabetes technology & …, 2022 - liebertpub.com
Background: With the proliferation of continuous glucose monitoring (CGM), a number of
metrics were developed to assess quality of glycemic control. Many of them are highly …
metrics were developed to assess quality of glycemic control. Many of them are highly …
Glycemia risk index as a novel metric to evaluate the safety of glycemic control in children and adolescents with type 1 diabetes: an observational, multicenter, real-life …
C Piona, M Marigliano, C Roncarà… - Diabetes Technology …, 2023 - liebertpub.com
Glycemia risk index (GRI) is a novel composite metric for the evaluation of the safety of
glycemic management and control. The aim of this study was to evaluate GRI and its …
glycemic management and control. The aim of this study was to evaluate GRI and its …
Time in range is associated with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study
Objective: To evaluate the association between continuous glucose monitoring (CGM)-
based time in various ranges and the subsequent development of diabetic retinopathy …
based time in various ranges and the subsequent development of diabetic retinopathy …